<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01700465</url>
  </required_header>
  <id_info>
    <org_study_id>11-1437</org_study_id>
    <nct_id>NCT01700465</nct_id>
  </id_info>
  <brief_title>Estimating and Predicting Hemodynamic Changes During Hemodialysis</brief_title>
  <official_title>Estimating and Predicting Hemodynamic Changes During Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Machine learning techniques and algorithms originally developed for use in the field of&#xD;
      robotics can be applied to continuous, noninvasive physiological waveform data to discover&#xD;
      hidden, hemodynamic relationships. Newly developed algorithms can, in real-time: 1) estimate&#xD;
      acute blood loss volume, 2) monitor and estimate fluid resuscitation needs, 3) predict&#xD;
      cardiovascular collapse well ahead of any clinically significant changes in standard vital&#xD;
      signs, and 4) estimate intracranial pressure. We hypothesize that these same methods can be&#xD;
      used to monitor volume loss during hemodialysis, as well as predict intradialytic&#xD;
      hypotension, well before it occurs.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Collect physiological waveform data from patients undergoing hemodialysis at the&#xD;
           University of Colorado Hospital, Children's Hospital Colorado, and Fresenius Medical&#xD;
           Centers using non-invasive monitoring techniques.&#xD;
&#xD;
        2. Combine the physiological data from patient monitors with clinical and demographic data,&#xD;
           including age, gender, race, problem list, reason for dialysis, estimated dry weight,&#xD;
           volume removed, arterial and venous pressures, etc. for use in developing mathematical&#xD;
           models of hemodialysis.&#xD;
&#xD;
        3. Develop robust, real-time, computational models for:&#xD;
&#xD;
             -  estimating acute intravascular volume loss during hemodialysis&#xD;
&#xD;
             -  predicting an optimal, individual specific, intravascular volume to be removed&#xD;
                during a hemodialysis session&#xD;
&#xD;
             -  predicting intradialytic hypotension&#xD;
&#xD;
        4. Determine:&#xD;
&#xD;
             -  which non-invasive signals are relevant to each model type&#xD;
&#xD;
             -  which features extracted from these signals are relevant&#xD;
&#xD;
             -  which algorithms are capable of using the extracted features for each decision type&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute intravascular volume loss during hemodialysis</measure>
    <time_frame>one hemodialysis session (approx 3-4 hours)</time_frame>
    <description>development of algorithm to estimate acute intravascular volume loss during hemodialysis</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">241</enrollment>
  <condition>Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Hemodialysis</arm_group_label>
    <description>Patients undergoing hemodialysis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult and pediatric patients undergoing hemodialysis at Fresenius Medical Centers,&#xD;
        University of Colorado Hospital or Children's Hospital Colorado will be the population base&#xD;
        for enrollment in this study. Patients may have acute kidney injury or end stage renal&#xD;
        disease. Subjects may be inpatients or outpatients.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 2 - 89 years&#xD;
&#xD;
          -  Undergoing hemodialysis at the Fresenius Medical Centers, University of Colorado&#xD;
             Hospital or Children's Hospital Colorado&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  Incarcerated&#xD;
&#xD;
          -  Decisionally challenged&#xD;
&#xD;
          -  Positive for hepatitis B surface antigen&#xD;
&#xD;
          -  Limited access to or compromised monitoring sites for non-invasive finger and ear or&#xD;
             forehead sensors&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steve Moulton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Colorado</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fresenius Medical Center East Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Hospital</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fresenius Medical Center Central</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fresenius Medical Center Rocky Mountain</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>September 27, 2012</study_first_submitted>
  <study_first_submitted_qc>October 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2012</study_first_posted>
  <last_update_submitted>December 1, 2016</last_update_submitted>
  <last_update_submitted_qc>December 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Hemodynamics</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

